ESC 365 - Implication on how to best identify and treat HF patients with tricuspid regurgitation

Open Access

Implication on how to best identify and treat HF patients with tricuspid regurgitation

Session: Hot or not debate - transcatheter tricuspid interventions now and tomorrow

Topic: Valvular Heart Disease

Speaker: Doctor A. Vazir (London, GB)

Sponsored by Edwards Lifesciences

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Ali Vazir

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

6 more presentations in this session

Introduction

Speaker: Professor S. Windecker (Bern, CH) Professor M. Boehm (Homburg, DE)

Con - transcatheter tricuspid valve therapies are NOT hot and will remain only a niche

Speaker: Associate Professor M. Adamo (Brescia, IT)

Pro - transcatheter tricuspid valve therapies are HOT and are a foundation therapy for patients with HF and tricuspid regurgitation

Speaker: Professor P. Lurz (Mainz, DE)

Conclusion

Speaker: Associate Professor M. Adamo (Brescia, IT) Professor P. Lurz (Mainz, DE)

Update and current status on transcatheter therapies for tricuspid regurgitation

Speaker: Doctor S. Zieroth (Winnipeg, CA)

Access the full session

Hot or not debate - transcatheter tricuspid interventions now and tomorrow

Speakers: Doctor A. Vazir, Professor S. Windecker, Professor M. Boehm, Associate Professor M. Adamo, Professor P. Lurz...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources